tiprankstipranks
Trending News
More News >
Scinai Immunotherapeutics Ltd. Sponsored Adr (SCNI)
:SCNI
US Market

Scinai Immunotherapeutics (SCNI) Ratios

Compare
314 Followers

Scinai Immunotherapeutics Ratios

SCNI's free cash flow for Q3 2024 was $-1.48. For the 2024 fiscal year, SCNI's free cash flow was decreased by $ and operating cash flow was $73.45. See a summary of the company’s cash flow.
Ratios
TTM
Dec 23Dec 22Dec 21Dec 20
Liquidity Ratios
Current Ratio
1.16 6.15 7.30 0.17 3.86
Quick Ratio
1.16 6.15 7.30 0.17 3.86
Cash Ratio
0.74 6.02 7.11 0.15 3.82
Solvency Ratio
2.59 -0.18 -0.25 -0.04 -0.60
Operating Cash Flow Ratio
-4.66 -3.11 -3.04 -1.13 -4.06
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 -1.20 0.00
Net Current Asset Value
$ -641.00K$ -14.46M$ -13.21M$ -18.94M$ -31.18M
Leverage Ratios
Debt-to-Assets Ratio
0.10 0.80 0.90 1.18 1.13
Debt-to-Equity Ratio
0.12 -12.24 29.52 -4.60 -2.02
Debt-to-Capital Ratio
0.11 1.09 0.97 1.28 1.98
Long-Term Debt-to-Capital Ratio
0.03 1.10 0.97 0.00 2.11
Financial Leverage Ratio
1.23 -15.38 32.62 -3.90 -1.78
Debt Service Coverage Ratio
2.96 -2.08 3.30 0.14 -5.19
Interest Coverage Ratio
-0.87 -2.19 3.45 6.74 -5.30
Debt to Market Cap
0.13 3.60 0.82 0.60 0.47
Interest Debt Per Share
<0.01 141.04 183.03 191.63 517.93
Net Debt to EBITDA
0.03 -0.71 -1.12 6.53 -0.77
Profitability Margins
Gross Profit Margin
-46.74%0.00%0.00%0.00%0.00%
EBIT Margin
552.48%0.00%0.00%0.00%0.00%
EBITDA Margin
531.45%0.00%0.00%0.00%0.00%
Operating Profit Margin
-155.69%0.00%0.00%0.00%0.00%
Pretax Profit Margin
477.86%0.00%0.00%0.00%0.00%
Net Profit Margin
350.86%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin
477.86%0.00%0.00%0.00%0.00%
Net Income Per EBT
73.42%100.00%100.00%100.00%100.00%
EBT Per EBIT
-306.94%52.40%75.46%-60.74%139.37%
Return on Assets (ROA)
35.51%-21.41%-25.61%-7.83%-94.34%
Return on Equity (ROE)
-250.01%329.32%-835.64%30.52%167.85%
Return on Capital Employed (ROCE)
-17.78%-44.73%-36.75%-100.77%-80.95%
Return on Invested Capital (ROIC)
-17.20%-44.05%-36.29%13.63%-80.37%
Return on Tangible Assets
35.51%-21.41%-25.61%-7.83%-94.34%
Earnings Yield
24.39%-103.87%-24.74%-4.45%-41.68%
Efficiency Ratios
Receivables Turnover
10.34 0.00 0.00 0.00 0.00
Payables Turnover
2.88 0.00 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.12 0.00 0.00 0.00 0.00
Asset Turnover
0.10 0.00 0.00 0.00 0.00
Working Capital Turnover Ratio
1.12 0.00 0.00 0.00 0.00
Cash Conversion Cycle
-91.48 0.00 0.00 0.00 0.00
Days of Sales Outstanding
35.30 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
126.78 0.00 0.00 0.00 0.00
Operating Cycle
35.30 0.00 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
>-0.01 -38.54 -52.61 -203.67 -273.25
Free Cash Flow Per Share
>-0.01 -42.97 -53.60 -220.88 -299.60
CapEx Per Share
<0.01 4.43 0.94 17.22 26.34
Free Cash Flow to Operating Cash Flow
1.04 1.12 1.02 1.08 1.10
Dividend Paid and CapEx Coverage Ratio
-26.36 -8.69 -55.78 -11.83 -10.37
Capital Expenditure Coverage Ratio
-26.36 -8.69 -55.78 -11.83 -10.37
Operating Cash Flow Coverage Ratio
-5.28 -0.34 -0.26 -1.08 -0.59
Operating Cash Flow to Sales Ratio
-5.23 0.00 0.00 0.00 0.00
Free Cash Flow Yield
-304.00%-145.17%-22.81%-78.61%-32.25%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
4.10 -0.96 -4.04 -22.47 -2.40
Price-to-Sales (P/S) Ratio
1.78 0.00 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
1.78 -3.17 33.78 -6.86 -4.03
Price-to-Free Cash Flow (P/FCF) Ratio
-0.33 -0.69 -4.38 -1.27 -3.10
Price-to-Operating Cash Flow Ratio
-2.75 -0.77 -4.47 -1.38 -3.40
Price-to-Earnings Growth (PEG) Ratio
0.03 0.02 -0.01 0.23 -0.30
Price-to-Fair Value
1.78 -3.17 33.78 -6.86 -4.03
Enterprise Value Multiple
0.37 -1.24 -4.31 17.85 -4.18
Enterprise Value
2.41M 13.05M 44.78M 49.10M 92.90M
EV to EBITDA
0.37 -1.24 -4.31 17.85 -4.18
EV to Sales
1.94 0.00 0.00 0.00 0.00
EV to Free Cash Flow
-0.36 -1.61 -5.92 -2.01 -3.80
EV to Operating Cash Flow
-0.37 -1.80 -6.03 -2.18 -4.16
Tangible Book Value Per Share
<0.01 -9.34 6.96 -40.98 -230.68
Shareholders’ Equity Per Share
<0.01 -9.34 6.96 -40.98 -230.68
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.00 0.00 0.00
Revenue Per Share
<0.01 0.00 0.00 0.00 0.00
Net Income Per Share
<0.01 -30.74 -58.14 -12.51 -387.21
Tax Burden
0.73 1.00 1.00 1.00 1.00
Interest Burden
0.86 0.52 0.76 -0.61 1.39
Research & Development to Revenue
4.23 0.00 0.00 0.00 0.00
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.75 0.00 0.00 0.00 0.00
Income Quality
-1.76 1.25 0.90 17.42 0.71
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis